Kissei Pharmaceutical Co., Ltd. And Daiichi Pharmaceutical (JPN) Jointly Launch Urination Disorder Improving Drug

Published: May 12, 2006

Tokyo, May 11, 2006 (JCN) - On May 10, Kissei Pharmaceutical and Daiichi Pharmaceutical jointly announced that they will launch URIEF Cap. 2mg/ 4mg (silodosin), an agent for treating urination disorder associated with benign prostatic hypertrophy (BPH), on May 11.

Back to news